Cometriq regimen - a chemotherapy regimen consisting of cabozantinib that may be used in the treatment of follicular, medullary, papillary and hurthle cell thyroid carcinomas; hepatobiliary and kidney cancers.
Up to date info
Latest research - Cometriq regimen
|This medical article is a stub. You can help WikiMD by expanding it.|
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Cometriq regimen for any updates.